Abstract IA18: Interrogating anti-PD1 immunotherapy resistance mechanisms

免疫疗法 医学 免疫学 癌症研究
作者
Ravindra Uppaluri
出处
期刊:Clinical Cancer Research [American Association for Cancer Research]
标识
DOI:10.1158/1557-3265.aacrahns19-ia18
摘要

Background: The response rate of 15-20% with anti-PD1 targeting in head and neck squamous cell carcinoma (HNSCC) highlights the need for strategies to overcome resistance. We have focused on delineating mechanistic aspects of immune checkpoint response and resistance using novel clinical trial approaches coupled with analyses in high-fidelity immunocompetent murine oral carcinoma (MOC) model to study HNSCC immunobiology. Methods: Using the MOC HNSCC model, we generated anti-PD1 resistant models. Whole-exome sequencing and RNA-Seq were used to compare mutational burden and expression signatures. Time of flight mass cytometry (CyTOF) was used to analyze tumor microenvironment (TME) remodeling in response to checkpoint inhibition. 2-D coculture system was used to assess tumor recognition by MHC class I restricted cytotoxic T cells. Tumor cells were loaded with SIINFEKL peptide and OT1 T cells were used as effectors in T-cell cytotoxicity assays. The anti-PD1 resistant MOC model overexpressing CAS9 with high editing efficiency was generated for a genome-scale CRISPR screen. The Broad Institute Genomic Perturbation Platform Brie lentiviral library, including 78,637 gRNAs targeting 19,674 with 1000 controls, was transduced into this line to define modifiers of CD8+ T cell mediated killing. Ezh2 inhibitors and knockout lines were used in characterizing the role of EZH2 in antigen presentation and antitumor immunity. Results: To examine immunotherapy resistance we generated 2 independent anti-PD1 adaptive resistant cell line models, MOC1-esc1 and MOC1-esc2, from their isogenic MOC1 parental line. RNA-Seq showed that MOC1-esc1 upregulated Myc and E2F targets and lost inflammatory signatures whereas -esc2 tumors have upregulated DNA damage and unfolded protein response. When MOC1-esc tumors were retransplanted into naive mice, they exhibited resistance to anti-PD1, while remaining responsive to anti-CTLA4 treatment. To gain comprehensive insights into the tumor microenvironment (TME) as a contributor to adaptive resistance, we analyzed tumor-infiltrating lymphocytes (TIL) in naive MOC1 and MOC1-esc1 tumors using CyTOF with a panel of 38 markers. MOC1-esc1 tumors were highly infiltrated with regulatory T cells (Tregs) and M2-like tumor-associated macrophages (TAMs), while MOC1 tumors have more M1-like TAMs and neutrophils. Furthermore, we observed that both anti-PD1 and anti-CTLA4 treatment dramatically expanded CD8+ T cells and decreased neutrophils in MOC1-esc1 tumors. In responding MOC1-esc1 tumors, anti-CTLA4 treatment resulted in Treg depletion, decreased M2-like TAMs and neutrophils, as well as a striking increase in M1-like TAMs compared with isotype control treated tumors. In contrast, anti-PD1 treated MOC1-esc1 tumors showed decreased M1-like TAMs, while M2-like TAMs were increased compared with control. Depletion of Tregs, neutrophils, or repolarization of TAM using monoclonal antibodies confirmed their contribution in immunotherapy resistance. As the MOC1-esc1 line showed in vitro resistance to T-cell cytotoxicity compared to MOC1 and to define tumor cell intrinsic modulators of T-cell cytotoxicity, we then completed a genome-scale CRISPR screen in MOC1-esc1. This screen identified 355 candidate genes whose loss of function regulated T-cell cytotoxicity. Chromatin modifiers emerged as a major class of genes regulating T-cell recognition of tumor cells. We validated Ezh2 as a therapeutic target and showed that inhibition of this pathway enhanced Class I expression and sensitized MOC1-esc1 cells to T-cell killing in vitro. Analysis of human HNSCC cell line models and TCGA data revealed conservation of Ezh2 impact on Class I expression. Combination therapy with Ezh2 inhibitors and anti-PD1 blockade resulted in enhanced therapeutic efficacy compared to either agent alone in the anti-PD1 resistant MOC1-esc1 model. Conclusions: In summary, this study identified (1) immune modulators within TME involved in adaptive immunotherapy resistance of HNSCC and remodeling with checkpoint therapy and (2) tumor cell intrinsic candidate pathways regulating T-cell recognition. Findings from these studies will advance our understanding of HNSCC immunotherapy resistance and will accelerate the discovery of new combination therapeutic targets and biomarkers in adaptive resistance. Citation Format: Ravindra Uppaluri. Interrogating anti-PD1 immunotherapy resistance mechanisms [abstract]. In: Proceedings of the AACR-AHNS Head and Neck Cancer Conference: Optimizing Survival and Quality of Life through Basic, Clinical, and Translational Research; 2019 Apr 29-30; Austin, TX. Philadelphia (PA): AACR; Clin Cancer Res 2020;26(12_Suppl_2):Abstract nr IA18.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
小跑阿甘完成签到 ,获得积分10
1秒前
Zack发布了新的文献求助10
1秒前
老王发布了新的文献求助10
2秒前
hmv发布了新的文献求助10
2秒前
liuwx发布了新的文献求助10
2秒前
4秒前
jjjwwww发布了新的文献求助10
5秒前
6秒前
陌桑子完成签到 ,获得积分10
7秒前
wuhao1完成签到,获得积分10
7秒前
hahahahaha完成签到,获得积分10
7秒前
闪闪芷波完成签到,获得积分20
8秒前
ljh发布了新的文献求助10
8秒前
callmecjh完成签到,获得积分10
9秒前
Nole的应助被朝夕采纳,获得10
10秒前
10秒前
华无剑的应助被朝夕采纳,获得10
10秒前
赘婿的应助被朝夕采纳,获得10
10秒前
假面绅士发布了新的文献求助10
11秒前
闪闪芷波发布了新的文献求助20
11秒前
12秒前
13秒前
共享精神的应助被开心德地采纳,获得10
13秒前
13秒前
13秒前
星辰大海的应助被amiee采纳,获得10
13秒前
molihuakai的应助被科研通管家采纳,获得10
14秒前
Owen的应助被科研通管家采纳,获得10
14秒前
共享精神的应助被科研通管家采纳,获得10
14秒前
More的应助被这题不讲采纳,获得10
14秒前
JamesPei的应助被科研通管家采纳,获得10
14秒前
14秒前
shihuishui完成签到,获得积分10
15秒前
思源的应助被科研通管家采纳,获得10
15秒前
Jun的应助被科研通管家采纳,获得20
15秒前
所所的应助被科研通管家采纳,获得10
15秒前
15秒前
Nole的应助被jing采纳,获得10
15秒前
星辰大海的应助被科研通管家采纳,获得10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188885
求助须知:如何正确求助?哪些是违规求助? 9576442
关于积分的说明 21847777
捐赠科研通 7786897
什么是DOI,文献DOI怎么找? 3435446
关于科研通互助平台的介绍 2559654
邀请新用户注册赠送积分活动 2482383